baclofen has been researched along with Sjogren-Larsson Syndrome in 1 studies
Sjogren-Larsson Syndrome: An autosomal recessive neurocutaneous disorder characterized by severe ichthyosis MENTAL RETARDATION; SPASTIC PARAPLEGIA; and congenital ICHTHYOSIS. It is caused by mutation of gene encoding microsomal fatty ALDEHYDE DEHYDROGENASE leading to defect in fatty alcohol metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current treatment of spasticity in patients with Sjögren-Larsson syndrome is largely symptomatic, given that no effective causal therapy treatments are available." | 5.46 | Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome. ( Harter, DH; Hersh, A; Hidalgo, ET; Orillac, C; Rizzo, WB; Weiner, HL, 2017) |
| "The current treatment of spasticity in patients with Sjögren-Larsson syndrome is largely symptomatic, given that no effective causal therapy treatments are available." | 1.46 | Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome. ( Harter, DH; Hersh, A; Hidalgo, ET; Orillac, C; Rizzo, WB; Weiner, HL, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidalgo, ET | 1 |
| Orillac, C | 1 |
| Hersh, A | 1 |
| Harter, DH | 1 |
| Rizzo, WB | 1 |
| Weiner, HL | 1 |
1 other study available for baclofen and Sjogren-Larsson Syndrome
| Article | Year |
|---|---|
Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome.
Topics: Baclofen; Child, Preschool; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; M | 2017 |